GH mTOR PI3K IGF-1

// Insulin-Like Growth Factor Research

IGF-1:
The Growth
Mediator

IGF-1 and its variants — LR3, DES, and MGF — are among the most studied peptides in growth and recovery research. A comprehensive guide to the science.

Explore Variants Mechanism
3+
Main Variants
70aa
Amino Acids
12hr
LR3 Half-Life
⚠

This site is for research and educational purposes only. IGF-1 variants are not approved by the FDA for human use outside specific medical conditions. Nothing here constitutes medical advice. Consult a licensed physician.

// IGF-1 Variants

The Three Main Variants

IGF-1 LR3
Long Arg3 IGF-1

A modified analog with an arginine substitution at position 3 and an N-terminal extension. The extension significantly reduces binding to IGF-binding proteins, dramatically extending half-life and bioavailability compared to native IGF-1.

Half-life~12–15 hrs
vs. Native IGF-13x more potent
IGFBP bindingSignificantly reduced
IGF-1 DES
Des(1-3) IGF-1

A truncated form of IGF-1 lacking the first three amino acids of the N-terminus. This truncation paradoxically increases receptor binding affinity 10-fold over native IGF-1, making it the most potent variant — but with a much shorter half-life.

Half-life~20–30 min
Receptor affinity~10x native
Best useLocal/site injection
MGF
Mechano Growth Factor

A splice variant of IGF-1 produced locally in muscle tissue in response to mechanical stress and damage. MGF activates satellite cells (muscle stem cells) and plays a key role in muscle repair and hypertrophy signaling.

OriginLocal muscle production
TriggerMechanical load/damage
Primary roleSatellite cell activation

// Signaling Pathway

How IGF-1 Signals

IGF-1 / LR3 IGF-1R Binding PI3K → AKT RAS → MAPK mTOR → S6K1 ERK1/2 Protein Synthesis / Growth
01
Receptor Binding
IGF-1 binds the IGF-1 receptor (IGF-1R), a tyrosine kinase receptor expressed in most tissues. Binding activates receptor autophosphorylation, initiating downstream signaling cascades.
02
Dual Pathway Activation
Two primary cascades activate simultaneously: the PI3K/AKT/mTOR pathway (anabolic, anti-apoptotic) and the RAS/MAPK/ERK pathway (proliferative, differentiation-related).
03
mTOR Downstream Effects
mTOR activation drives ribosomal protein synthesis, protein translation, and cellular growth. S6K1 phosphorylation is the key effector for muscle protein synthesis.
04
IGFBP Regulation
In circulation, ~99% of IGF-1 is bound to insulin-like growth factor binding proteins (IGFBPs), which regulate bioavailability. LR3's reduced IGFBP affinity is the primary reason for its extended activity.

// Research Areas

Studied Applications

💪
Muscle Protein Synthesis
IGF-1 is a primary driver of muscle protein synthesis via mTOR. Elevated local IGF-1 is well-documented to promote satellite cell activation and muscle hypertrophy in research models.
Strong Evidence
🔥
Fat Metabolism
IGF-1 has demonstrated lipolytic effects in adipose tissue. Research suggests improved insulin sensitivity and partitioning of nutrients toward lean tissue when IGF-1 is elevated.
Moderate Evidence
🦴
Bone Density
IGF-1 plays a critical role in skeletal growth and bone mineral density. Low IGF-1 is strongly associated with osteoporosis risk. Replacement therapy is well-established in IGF-1 deficiency.
Strong Evidence
🧠
Neuroprotection
Emerging research suggests IGF-1 has neuroprotective properties. It promotes neuronal survival, supports myelin maintenance, and may play a role in age-related cognitive decline.
Moderate Evidence
🩹
Tissue Repair
MGF variant in particular has demonstrated significant roles in local tissue repair following injury or exercise-induced damage, driving satellite cell proliferation and differentiation.
Moderate Evidence
⏱️
Longevity Research
The relationship between IGF-1 and longevity is complex — high IGF-1 supports tissue maintenance, but some longevity models show reduced IGF-1 signaling. Research is ongoing.
Active Research
Three
variants.
One
system.

IGF-1, LR3, DES, and MGF each occupy a different niche within the same signaling system. Understanding their distinct half-lives, binding properties, and tissue selectivity is key to understanding the research literature.

PubMed Research →